Ryan Zimmerman

Q: What is Ryan Zimmerman's success rate?

Ryan Zimmerman currently has a success rate of 89.60794739407035.

Q: What is the average return of Ryan Zimmerman's calls?

Their stock ratings have generated an average return of 3.7030626237063435.

BTIG | Healthcare

Ryan Zimmerman is an analyst from BTIG specializing in the Healthcare sector. Ranked #1736 out of 4580 analysts, they have issued 63 stock ratings with a success rate of 89.61% and an average return of 3.70%.

Ryan Zimmerman has a well-established track record, with 63 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 89.61% and an average return of 3.70%, underscoring their expertise and ability to identify winning opportunities for investors.

#1736

Out of 4580

Total Ratings

+89.61%

Success Rate

+3.70%

Average Return

Recent Ratings Analysis

LNSR

Buy

Mar 18, 2026

Target

$10.00

Current

$6.89

Performance

—

Ryan Zimmerman rated LNSR as Buy on Mar 18, 2026, setting a price target of 10. Shares have remained stable near 6.89, leaving the 10 target still in play.

SI

Buy

Mar 11, 2026

Target

$24.00

Current

$15.12

Performance

7.92%

On Mar 11, 2026, SI was given a Buy rating by Ryan Zimmerman, with a target price of 24. The stock rallied 7.92% after the rating, narrowing the gap to the target of 24 and validating the bullish stance.

SOLV

Buy

Feb 27, 2026

Target

$100.00

Current

$68.67

Performance

-7.45%

SOLV received a Buy rating from Ryan Zimmerman on Feb 27, 2026, aiming for 100. The rating hasn’t played out as hoped, with the stock trading 7.45% below expectations.

ORGO

Buy

Feb 27, 2026

Target

$9.00

Current

$2.53

Performance

-21.18%

On Feb 27, 2026, Ryan Zimmerman published a Buy outlook on ORGO, with a target of 9. Market action contradicted the Buy thesis, as shares slipped to 2.53.

KIDS

Buy

Feb 27, 2026

Target

$24.00

Current

$17.21

Performance

-10.22%

Ryan Zimmerman on Feb 27, 2026 assigned KIDS a Buy rating, with a price target of 24. The call has struggled to gain traction, with shares losing 10.22%.

ENOV

Buy

Feb 26, 2026

Target

$43.00

Current

$23.46

Performance

-7.71%

On Feb 26, 2026, Ryan Zimmerman reaffirmed ENOV with a Buy rating, targeting 43. Shares slid 7.71% despite the recommendation, highlighting downside risks.

ALC

Buy

Feb 25, 2026

Target

$92.00

Current

$77.78

Performance

-9.84%

ALC was rated Buy by Ryan Zimmerman on Feb 25, 2026, with a price objective of 92. This case shows how bullish projections can fail, with the stock now below 77.78.

TCMD

Buy

Feb 18, 2026

Target

$38.00

Current

$27.41

Performance

-17.07%

On Feb 18, 2026, Ryan Zimmerman initiated coverage on TCMD with a Buy rating and target of 38. The Buy call has yet to be validated as shares remain 10.59 away from the target.

GKOS

Buy

Feb 18, 2026

Target

$131.00

Current

$102.93

Performance

-14.93%

Ryan Zimmerman issued a Buy recommendation for GKOS on Feb 18, 2026, price target set at 131. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

ZBH

Buy

Feb 10, 2026

Target

$112.00

Current

$92.52

Performance

1.23%

On Feb 10, 2026, ZBH was evaluated by Ryan Zimmerman, who gave a Buy rating and target of 112. So far, the Buy call awaits clearer momentum, with shares flat at 92.52.

MDAI

Buy

Feb 10, 2026

Target

$3.00

Current

$1.28

Performance

-17.95%

Ryan Zimmerman rated MDAI as Buy on Feb 10, 2026, setting a price target of 3. The stock has underperformed, dropping 17.95% despite the bullish target of 3.

GEHC

Buy

Feb 09, 2026

Target

$91.00

Current

$72.34

Performance

-8.52%

On Feb 09, 2026, GEHC was given a Buy rating by Ryan Zimmerman, with a target price of 91. Despite the Buy call, shares fell from 72.34 to 72.34, challenging the optimistic stance.

HUMA

Buy

Feb 09, 2026

Target

$6.00

Current

$1.16

Performance

-4.92%

HUMA received a Buy rating from Ryan Zimmerman on Feb 09, 2026, aiming for 6. Price action was muted, as shares hovered around 1.16 despite the bullish outlook.

SYK

Buy

Jan 30, 2026

Target

$412.00

Current

$349.11

Performance

-5.53%

On Jan 30, 2026, Ryan Zimmerman published a Buy outlook on SYK, with a target of 412. Market action contradicted the Buy thesis, as shares slipped to 349.11.

ISRG

Buy

Jan 23, 2026

Target

$616.00

Current

$482.76

Performance

-7.87%

Ryan Zimmerman on Jan 23, 2026 assigned ISRG a Buy rating, with a price target of 616. The call has struggled to gain traction, with shares losing 7.87%.

PEN

Hold

Jan 16, 2026

Target

$349.00

Current

$338.00

Performance

-3.64%

On Jan 16, 2026, Ryan Zimmerman reaffirmed PEN with a Neutral rating, targeting 349. The neutral call matched muted market action of -3.64%.

CARL

Buy

Dec 15, 2025

Target

$24.00

Current

$11.70

Performance

-9.37%

CARL was rated Buy by Ryan Zimmerman on Dec 15, 2025, with a price objective of 24. This case shows how bullish projections can fail, with the stock now below 11.7.

RBOT

Hold

Dec 12, 2025

Target

—

Current

$0.90

Performance

-64.84%

On Dec 12, 2025, Ryan Zimmerman initiated coverage on RBOT with a Neutral rating and target of null. The rating matched the stock’s inability to hold above 0.9.

RCEL

Hold

Nov 20, 2025

Target

—

Current

$4.47

Performance

16.41%

Ryan Zimmerman issued a Neutral recommendation for RCEL on Nov 20, 2025, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

XTNT

Buy

Nov 11, 2025

Target

$1.50

Current

$0.60

Performance

-20.27%

On Nov 11, 2025, XTNT was evaluated by Ryan Zimmerman, who gave a Buy rating and target of 1.5. Investors saw limited payoff as shares fell short of the 1.5 target.

TMCI

Hold

Nov 07, 2025

Target

—

Current

$1.46

Performance

-67.34%

Ryan Zimmerman rated TMCI as Neutral on Nov 07, 2025, setting a price target of null. The cautious Hold call aligned with subsequent weakness, as shares slipped 67.34%.

HOLX

Hold

Oct 21, 2025

Target

—

Current

$75.05

Performance

1.45%

On Oct 21, 2025, HOLX was given a Neutral rating by Ryan Zimmerman, with a target price of null. Market indecision, reflected in sideways trading near 75.05, supported the cautious call.

IRTC

Buy

Oct 13, 2025

Target

$195.00

Current

$117.53

Performance

-33.74%

IRTC received a Buy rating from Ryan Zimmerman on Oct 13, 2025, aiming for 195. The rating hasn’t played out as hoped, with the stock trading 33.74% below expectations.

VCEL

Hold

Sep 17, 2025

Target

—

Current

$32.50

Performance

8.26%

On Sep 17, 2025, Ryan Zimmerman published a Neutral outlook on VCEL, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

PRCT

Hold

Sep 16, 2025

Target

—

Current

$27.36

Performance

-30.86%

Ryan Zimmerman on Sep 16, 2025 assigned PRCT a Neutral rating, with a price target of null. The call successfully avoided chasing as shares lost 30.86%.

RXST

Hold

Jul 09, 2025

Target

—

Current

$7.56

Performance

-4.91%

On Jul 09, 2025, Ryan Zimmerman reaffirmed RXST with a Neutral rating, targeting null. The neutral call matched muted market action of -4.91%.

GMED

Buy

Dec 12, 2024

Target

$91.00

Current

$88.16

Performance

6.59%

GMED was rated Buy by Ryan Zimmerman on Dec 12, 2024, with a price objective of 91. A bullish response from the market helped close the gap of 2.84 to the target.

IART

Hold

Oct 07, 2024

Target

—

Current

$9.10

Performance

-47.79%

On Oct 07, 2024, Ryan Zimmerman initiated coverage on IART with a Neutral rating and target of null. The rating matched the stock’s inability to hold above 9.1.

STAA

Buy

Jul 15, 2024

Target

$53.00

Current

$17.85

Performance

-60.53%

Ryan Zimmerman issued a Buy recommendation for STAA on Jul 15, 2024, price target set at 53. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Frequency Asked Questions

Who is Ryan Zimmerman?

Ryan Zimmerman is an analyst from BTIG specializing in the Healthcare sector.

What is Ryan Zimmerman's success rate?

Ryan Zimmerman currently has a success rate of +89.61%.

How many ratings has Ryan Zimmerman issued?

Ryan Zimmerman has issued 63 stock ratings so far.

What is the average return of Ryan Zimmerman's calls?

Their stock ratings have generated an average return of +3.70%.

What is Ryan Zimmerman's ranking?

Ryan Zimmerman is ranked #1736 out of 4580 analysts.

What types of ratings does Ryan Zimmerman give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Ryan Zimmerman?

You can follow Ryan Zimmerman by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Ryan Zimmerman?

Their latest rating was a Buy on LNSR issued on 2026-03-18.